Apogem Capital’s Freeport-McMoran FCX Stock Holding History

Apogem Capital’s Portfolio FCX Stock Details FCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,478	Closed	-$479K	–	182
2021 Q4	$479K	Buy	+11,478	New	+$436K	0.31%	99

Other funds holding FCX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Apogem Capital's FCX Position: Q1 2022 in Review

Apogem Capital sold out of Freeport-McMoran (FCX) in Q1 2022, closing a stake of 11,478 shares — an estimated $479K sold.

Apogem Capital first reported a position in FCX in Q4 2021 and held it in 1 quarter. The position peaked at $479K in Q4 2021. 1,264 funds tracked by Wall St. Rank hold FCX as of Q1 2022.

Apogem Capital reported no remaining Freeport-McMoran position as of Q1 2022 after selling out during the quarter.
Apogem Capital sold 11,478 Freeport-McMoran shares in Q1 2022, an estimated $479K.
Apogem Capital first reported a position in Freeport-McMoran in Q4 2021 and held it in 1 quarter.
Apogem Capital's Freeport-McMoran position peaked at $479K in Q4 2021.
1,264 funds tracked by Wall St. Rank held Freeport-McMoran as of Q1 2022.

Based on Apogem Capital's 13F filing for Q1 2022, filed 16 May 2022.